Skip to content
BY 4.0 license Open Access Published by De Gruyter Open Access June 15, 2022

Complementary and alternate therapies (CAM) in the management of novel Corona virus (COVID-19): protocol for systematic review and meta-analysis

  • Kuppusamy Maheshkumar EMAIL logo , Vijayakumar. Venugopal , Sankar Geethanjali , Shanmugam Poonguzhali , Santhi Silambanan , Ramaswamy Padmavathi and Sankaralingam Thirupathy Venkateswaran
From the journal Open Health

Abstract

Background: In December 2019, a new corona-virus (COVID-19) infection broke out in the Chinese province of Wuhan. With the rampant spread of virus around the world, COVID-19 was declared as a global pandemic in the following year. Many complementary and alternate therapies (CAM) were used experimentally alongside conventional treatments for effective management of COVID-19.

Aim: This paper presents a protocol for the systematic review and meta-analysis of the studies with various CAM therapies for the management of COVID-19 pneumonia.

Methods: Electronic databases such as PubMed, Embase, Scopus, and the Cochrane Central Register of Controlled Trials (CENTRAL) could be used for searching the relevant trials and studies with keywords related to COVID-19 and CAM therapies. Two independent reviewers would screen a list of all the trials and extract the relevant variables. Additionally, we would also evaluate the risk of bias of the selected studies. Review Manager software (RevMan; version 5.3.5) and R statistical software (version 3.6.1) would be used for the data analysis.

Results: Risk ratio (RR) would be estimated for dichotomous outcomes, and the mean differences (MD) would be measured for continuous outcomes. Heterogeneity with the help of I2 statistic would be used for the assessment of inconsistency across studies with the level of significance at P< 0.10. We would also assess publication bias using funnel plots and Egger’s test for the selected studies.

Conclusion: The protocol for systematic review and meta-analysis would investigate the beneficial and possible adverse effects of various CAM therapies in the prevention and management of COVID-19 associated pneumonia.

References

[1] Lai C-C, Shih T-P, Ko W-C, Tang H-J, Hsueh P-R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges. Int. J. Antimicrob. Agents. 2020 Mar;55(3):105924.10.1016/j.ijantimicag.2020.105924Search in Google Scholar PubMed PubMed Central

[2] Loganathan S, Kuppusamy M, Wankhar W, Gurugubelli KR, Mahadevappa VH, Lepcha L, et al. Angiotensin-converting enzyme 2 (ACE2): COVID 19 gate way to multiple organ failure syndromes. Respir Physiol Neurobiol. 2021 Jan;283:103548.10.1016/j.resp.2020.103548Search in Google Scholar PubMed PubMed Central

[3] Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, Xia Z. Review of the clinical characteristics of coronavirus disease 2019 (COVID-19). J Gen Intern Med. 2020 May;35(5)1545-9.10.1007/s11606-020-05762-wSearch in Google Scholar PubMed PubMed Central

[4] Zumla A, Hui DS, Perlman S. Middle East respiratory syndrome. Lancet. 2015 Sep 5;386(9997):995-1007.10.1016/S0140-6736(15)60454-8Search in Google Scholar PubMed PubMed Central

[5] Halaji M, Farahani A, Ranjbar R, Heiat M, Dehkordi FS. Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19. Infez Med. 2020 Jun;28(suppl 1):6-17.Search in Google Scholar

[6] Halaji M, Heiat M, Faraji N, Ranjbar R. Epidemiology of COVID-19: An updated review. J Res Med Sci. 2021 Sep;26:82Search in Google Scholar

[7] Maheshkumar K, Venugopal V, Poonguzhali S, Mangaiarkarasi N, Venkateswaran ST, Manavalan N. Trends in the use of Yoga and Naturopathy based lifestyle clinics for the management of Non-communicable diseases (NCDs) in Tamilnadu, South India. Clin Epidemiol Glob Health. 2020 Jun;8(2):647-51.10.1016/j.cegh.2019.09.013Search in Google Scholar

[8] Mirzaie A, Halaji M, Dehkordi FS, Ranjbar R, Noorbazargan H. A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19). Complement Ther Clin Pract. 2020 Aug;40:101214.10.1016/j.ctcp.2020.101214Search in Google Scholar PubMed PubMed Central

[9] Venugopal V, Pamavathi R, Venkateswaran ST, Gunasekaran D, Maheshkumar K. Protecting the elders from COVID-19 impact-leveraging yoga. J Family Med Prim Care 2020 Aug;9(8):4487-8.10.4103/jfmpc.jfmpc_797_20Search in Google Scholar PubMed PubMed Central

[10] Hong Z, Yisong L, Bing L. Nine cases of the chronic stage of SARS treated by moxibustion. Chin Acupunct Moxibust. 2003;9.Search in Google Scholar

[11] Nilashi M, Samad S, Yusuf SYM, Akbari E. Can complementary and alternative medicines be beneficial in the treatment of COVID-19 through improving immune system function?. J Infect Public Health. 2020 Jun;13(6):893-6.10.1016/j.jiph.2020.05.009Search in Google Scholar PubMed PubMed Central

[12] Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015 Jan;350:g7647.10.1136/bmj.g7647Search in Google Scholar PubMed

[13] Higgins JP, Sterne JA, Savovic J, Page MJ, Hróbjartsson A, Boutron I, et al. A revised tool for assessing risk of bias in randomized trials. Cochrane Database Syst Rev 2016;10(Suppl 1):29-31.Search in Google Scholar

[14] Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane handbook for systematic reviews of interventions. John Wiley & Sons; 2019.10.1002/9781119536604Search in Google Scholar

[15] Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004 Jun;328(7454):1490.10.1136/bmj.328.7454.1490Search in Google Scholar PubMed PubMed Central

[16] Jerrin RJ, Theebika S, Panneerselvam P, Manavalan N, Maheshkumar K. Yoga and Naturopathy intervention for reducing Anxiety and Depression of Covid-19 patients–a pilot study. Clin Epidemiol Glob Health. 2021 Jul-Sep;11:100800.10.1016/j.cegh.2021.100800Search in Google Scholar PubMed PubMed Central

[17] Kathiresan N, Arunthathi R, Venugopal V, Narayanaswamy K, Manavalan N, Maheshkumar K. “It is the best part of our Hospital life”: A Qualitative analysis on the impact of Yoga and Naturopathy as a Complementary therapy in the management of COVID-19. Asian J Psychiatr. 2021 Oct;64:102789.10.1016/j.ajp.2021.102789Search in Google Scholar PubMed PubMed Central

[18] Liu X, Zhang M, He L, Li Y. Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS). Cochrane Database Syst Rev. 2012 Oct;2012(10): CD004882.10.1002/14651858.CD004882.pub3Search in Google Scholar PubMed PubMed Central

[19] Hwang JH, Cho HJ, Im HB, Jung YS, Choi SJ, Han D. Complementary and alternative medicine use among outpatients during the 2015 MERS outbreak in South Korea: a cross-sectional study. BMC Complement Med Ther. 2020 May;20(1):147.10.1186/s12906-020-02945-0Search in Google Scholar PubMed PubMed Central

[20] Cramer H, Posadzki P, Dobos G, Langhorst J. Yoga for asthma: a systematic review and meta-analysis. Ann Allergy Asthma Immunol. 2014 Jun;112(6):503-10.e.5.10.1016/j.anai.2014.03.014Search in Google Scholar PubMed

[21] Cramer H, Lauche R, Langhorst J, Dobos G. Yoga for depression: A systematic review and meta-analysis. Depress Anxiety. 2013 Nov;30(11):1068-83.10.1002/da.22166Search in Google Scholar PubMed

[22] Cramer H, Lauche R, Anheyer D, Pilkington K, de Manincor M, Dobos G, et al. Yoga for anxiety: A systematic review and meta-analysis of randomized controlled trials. Depression Anxiety. 2018 Sep;35(9):830-43.10.1002/da.22762Search in Google Scholar PubMed

Received: 2022-02-07
Accepted: 2022-05-06
Published Online: 2022-06-15

© 2022 Kuppusamy Maheshkumar et al., published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Downloaded on 29.3.2024 from https://www.degruyter.com/document/doi/10.1515/openhe-2022-0009/html
Scroll to top button